DESI-MS Solvent Composition for Tissue Morphology Preservation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current mass spectrometry techniques, such as DESI-MS, destroy the native tissue morphology during analysis, preventing their integration into routine histopathology workflows due to the inability to perform subsequent histochemical analyses on the same tissue section.

Innovation Solution

The use of solvent systems like DMF:EtOH and DMF:H2O for DESI-MS imaging that preserve tissue morphology, allowing subsequent histochemical analyses like H&E staining and immunohistochemistry on the same tissue section.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Loss of information

If conventional DESI-MS techniques are used for tissue analysis, then molecular information is obtained, but tissue morphology is destroyed

Engineering Contradiction:
Improvemolecular informationVSAvoidtissue morphology
Core Design Contradiction:
Loss of informationVSShape

Solution Approach 1:

The invention changes the chemical composition parameters of the solvent system by incorporating DMF (dimethylformamide) and ethanol in specific ratios, along with formic acid modification. This parameter change allows the solvent to extract molecular information while being less destructive to tissue morphology compared to conventional solvents like acetonitrile or methanol mixtures.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention uses a composite solvent system combining multiple chemicals (DMF, ethanol, formic acid) rather than a single solvent. This composite approach creates a balanced chemical environment that achieves both molecular extraction and tissue preservation, resolving the contradiction between obtaining molecular information and maintaining tissue morphology.

Inventive Principle:
Principle #40Composite materials

2Measurement precision

If multiple analyses are performed on the same tissue section, then diagnostic accuracy is enhanced, but tissue integrity is compromised

Engineering Contradiction:
Improvediagnostic accuracyVSAvoidtissue integrity
Core Design Contradiction:
Measurement precisionVSStability of the object's composition

Solution Approach 1:

The invention performs DESI-MS analysis with a morphology-preserving solvent system before conducting histochemical staining. The preliminary DESI-MS analysis does not compromise the tissue structure, allowing subsequent staining procedures to be performed on the same section, thereby enabling multiple analyses while maintaining tissue integrity.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

By changing the solvent parameters to use DMF-based formulations, the tissue stability is maintained during mass spectrometry analysis. This parameter change allows the tissue to withstand multiple analytical procedures including both DESI-MS and subsequent histochemical staining without degradation.

Inventive Principle:
Principle #35Parameter changes

3Productivity

If standard solvent systems are used for DESI-MS, then analysis speed is maintained, but tissue damage occurs

Engineering Contradiction:
Improveanalysis speedVSAvoidtissue damage
Core Design Contradiction:
ProductivityVSObject-affected harmful factors

Solution Approach 1:

The invention modifies the solvent system parameters by using DMF as the primary solvent instead of conventional acetonitrile or methanol. This parameter change maintains the rapid ionization capability needed for fast analysis while significantly reducing tissue damage, thus preserving both productivity and reducing harmful effects on the tissue.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables non-destructive mass spectrometry analysis of tissues, maintaining tissue integrity for subsequent histochemical examinations, thereby enhancing diagnostic accuracy by correlating molecular and histological data.

Implementation Method 1

mass spectrometry technique, in which the technique utilizes a liquid phase that does not destroy native tissue morphology during analysis

Methodology Applied
Scientific EffectIonization: Ionisation

Implementation Method 2

desorption electrospray ionization mass spectrometry

Methodology Applied
Scientific EffectDesorption: Desorption

Implementation Method 3

desorption electrospray ionization mass spectrometry (DESI-MS)

Methodology Applied
Scientific EffectElectrospray ionization: Electrostatics

Data Source

PatentUS12535492B2Mass spectral tissue analysis
Publication Date: 2026.01.27 PURDUE RES FOUND
  • US12535492B2 patent drawing
  • US12535492B2 patent drawing
  • US12535492B2 patent drawing

AI summary

The invention generally relates to mass spectral analysis. In certain embodiments, methods of the invention involve analyzing a lipid containing sample using a mass spectrometry technique, in which the technique utilizes a liquid phase that does not destroy native tissue morphology during analysis.